BNP Paribas Asset Management
EVH icon

BNP Paribas Asset Management’s Evolent Health EVH Stock Holding History

BNP Paribas Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,768
Closed -$7K – 2284
2025
Q4 		$7K Buy
+1,768
New +$9.83K ﹤0.01% 2243
2025
Q3 		– Sell
-823
Closed -$9K – 1937
2025
Q2 		$9K Buy
+823
New +$7.56K ﹤0.01% 1808

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management's EVH Position: Q1 2026 in Review

BNP Paribas Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 1,768 shares — an estimated $7K sold.

BNP Paribas Asset Management first reported a position in EVH in Q2 2025 and held it in 2 quarters. The position peaked at $9K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • BNP Paribas Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 1,768 Evolent Health shares in Q1 2026, an estimated $7K.
  • BNP Paribas Asset Management first reported a position in Evolent Health in Q2 2025 and held it in 2 quarters.
  • BNP Paribas Asset Management's Evolent Health position peaked at $9K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.